Go to the profile of Le Bert

Le Bert

French 3Rs officer- 3Rs Project engineering - Open Science, French Centre 3R (GIS FC3R)
  • France
Go to the profile of Sümeyye Akçelik-Deveci
Sümeyye Akçelik-Deveci

Post Doctoral Researcher , boğaziçi university

Türkiye
Go to the profile of Adriana Murgoci
Adriana Murgoci

Senior Scientist, Brain Zell

Sweden
Go to the profile of Benchenouf
Benchenouf

PhD in pathophysiology, Université Paris-Saclay

France
Go to the profile of Eleanor McGuigan
Eleanor McGuigan

PhD Student, Queen Mary University London

United Kingdom
Go to the profile of Monika McDole-Russell
Monika McDole-Russell

CEO and Founder, Accivola Consulting

United States of America
Go to the profile of Thanchanok Khorporn
Thanchanok Khorporn

Miss, Chulalongkorn university

Thailand
Go to the profile of Florence Schlosser
Florence Schlosser

Senior Scientist II, Immunocore Ltd

United Kingdom
Go to the profile of Nikolina Kanjer
Nikolina Kanjer

Student , FPMOZ

Croatia
Go to the profile of Maria A. Núñez Sánchez
Maria A. Núñez Sánchez

Principal Investigator , Biomedical Research Institute of Murcia

Spain
Go to the profile of Simon Perrudin
Simon Perrudin

Master's Student , CEA-Irig

France
Go to the profile of Mehmet Girgin
Mehmet Girgin

Scientist, Roche

Switzerland
Go to the profile of Ulziituya Batjargal
Ulziituya Batjargal

PhD Student, Korea University

Korea (Republic of)
Go to the profile of Mohamed Fahad
Mohamed Fahad

Research Engineer, Technology Innovation Institute

United Arab Emirates
Go to the profile of Jorge Bernardino de la Serna
Jorge Bernardino de la Serna

Senior Lecturer, National Heart and Lung Institute

United Kingdom
Go to the profile of Janneke Hogervorst
Janneke Hogervorst

Science advisor, PETA UK

Belgium
Go to the profile of Alan Williams
Alan Williams

Company Director, Compare Biomarket

United Kingdom
Go to the profile of Mariana Guedes
Mariana Guedes

doctoral scientist, University of Saarland

Germany
Go to the profile of ANGILERI Francesca
ANGILERI Francesca

Associate Professor and PI at CICLY, center for innovation in cancerology of Lyon, UCBL1_HCL

My research is committed to developing a 3D liver model to better understand the secondary effects of anticancer agents. By investigating the link between pharmaco-toxicity and genotype-phenotype interactions, this work aims to improve patient follow-up and advance personalized medical care.
France
Go to the profile of Sharon Byras
Sharon Byras

Technical Specialist Biological and Preclinical, IDEXX BioAnalytics

United States of America
Go to the profile of Pelin Saglam-Metiner
Pelin Saglam-Metiner

Bioengineer, Ege University Bioengineering Department

Türkiye

Cookies

We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.

You can consent to the use of such technologies by closing this notice.

Cookie Control

Customise your preferences for any tracking technology

The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.

See the full cookie policy See the full privacy policy
More information

These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.

More information

These trackers help us to deliver personalized marketing content and to operate, serve and track ads.

More information

These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.

More information

These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.

More information

These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.